However, "allowed for cosmetic use" and "FDA-approved drug" are two different regulatory concepts
Recently, GPx4 was predicted to be a specific target for new pharmacological therapies aimed at activating or inhibiting cell death in cancer or degenerative diseases [110]
And then in 2019, I decided to build the company that we just sold, which really came from my awareness in the supplement space, which he had originally asked me and then my business partner, as formulation background, he had been in the biopharma space for over 20 years
30 , 32 Owing to the 1 week PK halflife of semaglutide, Santi 32 recently used PK simulations to show that oncemonthly dosing requires very high dose sizes to maintain drug concentrations above a presumed therapeutic threshold
But here's where I'm staying cautious: It's not FDA-approved
That is a very different statement from they do nothing. It means: The mechanistic rationale is real